DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Krishna N - 2 Poli Devi - 1 Janvi - 1 Anushree - 1 Koshia - 1 Norris's - 1 Norris - 1 Vimal Shah - 1
Top related locs:
India DELHI Gambia Uzbekistan Ramnagar Jammu Cameroon Gujarat
Top related orgs:
World Health Organization - 2 WHO - 2 Pharmaceuticals Export - 2 of India - 2 Thomson - 2 REUTERS - 1 Norris Medicines - 1 Central Drugs Standard Control - 1

Search resuls for: "Pharmaceuticals Export"


4 mentions found


☆ India finds two more toxic syrups months after poisoning deaths
  + stars: | 2023-10-04 | by ( Krishna N. Das Sumit Khanna | Krishna N. Das | Sumit Khanna | ) www.reuters.com   time to read: +4 min
Poli Devi, whose 11-month-old daughter Janvi was among the children who died due to kidney injury after consuming contaminated cough syrup, holds a photo of her at their house in Ramnagar on the outskirts of Jammu, India, March 28, 2023. REUTERS/Anushree Fadnavis/File Photo Acquire Licensing RightsNEW DELHI, Oct 4 (Reuters) - India's drug regulator has found that a cough syrup and an anti-allergy syrup made by Norris Medicines (NORI.BO) are toxic, according to a government report, months after Indian-made cough syrups were linked to 141 children's deaths worldwide. Koshia said Norris used to export the cough syrup, but did not say where. "We are aware of the CDSCO report and have communicated with that agency to ascertain where the products... have been exported," said a WHO spokeswoman. The CDSCO also found three batches of COLD OUT syrup made by Fourrts (India) Laboratories contaminated with DEG and EG.
Persons: Poli Devi, Janvi, Anushree, Koshia, Norris's, Norris, Vimal Shah, S.V, Veeramani, Adani Wilmar, Krishna N, Jennifer Rigby, Andrew Heavens, Nick Macfie, William Maclean Organizations: REUTERS, Norris Medicines, Central Drugs Standard Control, EG, Drug Control Administration, Reuters, World Health Organization, WHO, Laboratories, World Health Organisation, Fourrts, Pharmaceuticals Export, of India, Thomson Locations: Ramnagar, Jammu, India, DELHI, Gambia, Uzbekistan, Cameroon, Gujarat, Fourrts, Iraq, pharmexcil
☆ Exclusive: India pharma exports surging despite cough syrup deaths
  + stars: | 2023-07-25 | by ( Krishna N. Das | Thomson Reuters | As The Breaking News Editor For South Asia | ) www.reuters.com   time to read: +4 min
Two other cough syrups made in India killed 19 children in Uzbekistan around December, according to the Uzbekistan government. India's overall pharma exports in the April-June quarter rose 5% to $6.58 billion. COUNTRY VISITSPharmexcil delegations have visited countries including Nigeria, Egypt and Russia in recent months to allay any concerns about Indian drugs, he said. Apart from Gambia, no other country has asked for additional tests for Indian drugs since the deaths, he said. Manufacturing a drug in Europe or the United States costs more than 30% than in India, giving India a big advantage, he said.
Persons: syrups, Udaya Bhaskar, Bhaskar, drugmakers, Krishna N, Alison Williams Organizations: Reuters, World Health Organization, WHO, pharma, Pharmaceuticals Export, of India, India's pharma, Marion Biotech, Thomson Locations: DELHI, Gambia, India, Uzbekistan, United States, China, U.S, Nigeria, Egypt, Russia, South Africa, Brazil, Europe
☆ Uzbekistan says 18 children die after consuming India-made syrup
  + stars: | 2022-12-28 | by ( ) www.reuters.com   time to read: +2 min
NEW DELHI, Dec 28 (Reuters) - Uzbekistan's health ministry has said at least 18 children have died after consuming a medicinal syrup manufactured by Indian drugmaker Marion Biotech Pvt Ltd. The ministry said 18 out of 21 children who took the Doc-1 Max syrup while suffering from an acute respiratory disease died after consuming it. The syrup was imported into Uzbekistan by Quramax Medical LLC, the ministry said in its statement released on Tuesday. An Indian government source said the health ministry was looking into the matter. The Uzbek health ministry said it had dismissed seven employees for negligence for not analysing the deaths in a timely manner and not taking the necessary measures.
☆ India inspects drug factories as Gambia controversy lingers
  + stars: | 2022-12-27 | by ( ) www.reuters.com   time to read: +2 min
India is known as the "pharmacy of the world" and its pharmaceuticals exports have more than doubled over the past decade to $24.5 billion in the past fiscal year. The deaths of at least 70 children in Gambia has dented the industry's image, though India says the drugs made by New Delhi-based Maiden Pharmaceuticals Ltd were not at fault. "Joint inspections are being conducted all over the country as per standard operating procedures," the Ministry of Health and Family Welfare said in a statement. Some health experts say India's drug regulations are lax, especially at the level of states where thousands of factories operate. But India's main drugs officer told the World Health Organization this month that tests of samples from the same batches of syrups that Maiden sent to Gambia were compliant with government specifications.
0 next >>
Total: 4